Werewolf Therapeutics, Inc. (HOWL) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts HOWL Hot Sheet
Join SI Premium – FREE
Werewolf Therapeutics, Inc. (NASDAQ: HOWL) reported Q2 EPS of ($0.40), $0.07 better than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Werewolf Therapeutics, Inc. (HOWL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: not sure I want to make a deal with Iranian leaders
- Trump: I think Israel will withdraw troops from Lebanon
- TD Cowen on Prime Medicine (PRME): 'We continue to view PRME as undervalued for the platform’s potential'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
